You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 7,253,185


✉ Email this page to a colleague

« Back to Dashboard


Title:Amino ceramide-like compounds and therapeutic methods of use
Abstract: The present invention provides amino ceramide-like compounds which inhibit glucosyl ceramide (GlyCer) formation by inhibiting the enzyme GlyCer synthase, thereby lowering the level of glycosphingolipids. The compounds of the present invention have improved GlcCer synthase inhibition activity and are therefore useful in therapeutic methods for treating various conditions and diseases associated with altered glycosphingolipid levels.
Inventor(s): Shayman; James A. (Ann Arbor, MI), Harris; David J. (Lexington, MA), Siegel; Craig (Woburn, MA), Nelson; Carol A. (Westford, MA), Copeland; Diane P. (North Billerica, MA)
Assignee: The Regents of the University of Michigan (Ann Arbor, MI) Genzyme Corporation (Cambridge, MA)
Filing Date:Apr 29, 2005
Application Number:11/119,541
Claims:1. A pharmaceutical composition comprising a compound represented by the following structural formula: ##STR00006## or a stereoisomer, a pharmaceutically acceptable salt or a mixture thereof; and a pharmaceutically acceptable carrier or an excipient, wherein: R.sup.1 is a phenyl, a substituted phenyl group, a branched aliphatic group, or a 7-15 carbons long alkyl chain or a 7-15 carbons long alkenyl chain with a double bond next to the kernel; R.sup.2 is an alkyl group 6, 7, or 8 carbons long; and R.sup.3 is a pyrrolidine, azetidine or piperidine, in which the nitrogen atom is attached to the kernel.

2. The pharmaceutical composition of claim 1, wherein R.sup.1 is a phenyl group substituted with a functional group selected from the group consisting of a p-methoxy, hydroxyl, methylenedioxy, ethylenedioxy, trimethylenedioxy and cyclohexyl.

3. A pharmaceutical composition comprising a compound represented by the structural formula: ##STR00007## or a stereoisomer, a pharmaceutically acceptable salt or a mixture thereof; and a pharmaceutically acceptable carrier or an excipient, wherein: R.sup.1 is a substituted or unsubstituted phenyl group, a branched aliphatic group, or a 7-15 carbons long alkyl chain or a 7-15 carbons long alkenyl chain with a double bond next to the kernel; R.sup.2 is an alkyl group 6, 7, or 8 carbons long; and R.sup.3 is pyrrolidine, in which the nitrogen atom is attached to the kernel.

4. The pharmaceutical composition of claim 3, wherein R.sup.1 is a phenyl group substituted with a functional group selected from the group consisting of a p-methoxy, hydroxyl, methylenedioxy, ethylenedioxy, trimethylenedioxy and cyclohexyl.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.